MandarMuzumdarMD
Oncology • West Haven, CTGastrointestinal Cancer
Associate Professor of Genetics and of Internal Medicine (Medical Oncology, Cancer Biology Institute, Yale University School of Medicine Scientific Director, Center for Gastrointestinal Cancers, Smilow Cancer Hospital and Yale Cancer Center
Dr. Muzumdar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
840 W Campus Dr
Advanced Biosciences Center, 3rd Floor
West Haven, CT 06516
Education & Training
Koch Institute for Integrative Cancer ResearchPost-Doctoral Fellowship, 2011 - 2017
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2010 - 2014- Brigham and Women's HospitalResidency, Internal Medicine, 2008 - 2010
Stanford University School of MedicineClass of 2008
Certifications & Licensure
CT State Medical License 2017 - 2025
MA State Medical License 2011 - 2017- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Damon Runyon-Rachleff Innovation Award Damon Runyon Cancer Research Foundation, 2021
- Early Career Award Cancer Research journal, 2019
- New Innovator Award National Institutes of Health, 2019
- Join now to see all
Publications & Presentations
PubMed
- 2592 citationsA global double‐fluorescent Cre reporter mouseMandar Deepak Muzumdar, Bosiljka Tasic, Kazunari Miyamichi, Ling Li, Liqun Luo
Genesis. 2007-09-01 - 57 citationsModeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM).Mandar Deepak Muzumdar, Liqun Luo, Hui Zong
Proceedings of the National Academy of Sciences of the United States of America. 2007-03-13 - 29 citationsAdaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells.Pan-Yu Chen, Mandar Deepak Muzumdar, Kimberly Judith Dorans, Rebecca Robbins, Arjun Bhutkar
Cancer Research. 2017-01-01
Press Mentions
A Pressing Need for New Ideas for Pancreatic CancerFebruary 25th, 2021
Study Points to Obesity as Driver of Pancreatic CancerApril 16th, 2020
Grant Support
- K08National Cancer Institute2016–2021
- Research Investigator GrantLustgarten Foundation2015–2017
- KL2/CMeRITHarvard Medical School Catalyst and NIH2014–2016
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
